Kent Lake Capital »

Neuropace shares owned by Kent Lake Capital

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Kent Lake Capital from 13F filings

Historical chart of Kent Lake Capital investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Kent Lake Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Kent Lake Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 671k 10.31
2023-09-30 $5.6M 574k 9.73
2023-06-30 $670k 149k 4.49
2023-03-31 $592k 128k 4.64

More positions owned by Kent Lake Capital

Zimvie (ZIMV)
Allscripts Healthcare Solutions (MDRX)
Kyndryl Hldgs Common Stock (KD)
Vericel (VCEL)
FARO Technologies (FARO)
8x8 (EGHT)
Innovage Hldg Corp (INNV)
Ensign (ENSG)
Upwork (UPWK)
Nerdy Cl A Com (NRDY)
Fiverr Intl Ord Shs (FVRR)
Calavo Growers (CVGW)
Pennant Group (PNTG)
Si-bone (SIBN)
Caredx (CDNA)

View all positions for Kent Lake Capital

Top funds holding Neuropace

OrbiMed Advisors
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Vanguard Group
Millennium Management
Jane Street
Citigroup
Bank of America Corporation
Balyasny Asset Management
683 Capital Management
Citadel Advisors
Laurion Capital Management
Man Group
Townsquare Capital

View all funds holding Neuropace